MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Wednesday, January 28, 2015

Google, Biogen, Seek Reasons for Advance of Multiple Sclerosis

“Our central thesis is to change health care from being reactive to proactive,” Conrad said in a telephone interview. “We’re trying to understand disease at its onset and see if we can intervene early.”
Using sensors, software and data analysis tools, the companies will collect and sift through data from people with the disease. The goal is to explain why multiple sclerosis progresses differently from patient to patient, said Rick Rudick, Biogen’s vice president of development sciences.
“We used to see patients at the beginning stages of MS -- two women would come in with optic neuritis, they couldn’t see out of one eye, they’d have some spots on the MRI scan, and they looked very similar,” said Rudick, who previously was director of the Cleveland Clinic’s MS program. “But as we followed them along, 10 years later, one would be a championship tennis player still and one would be in a nursing home. I never understood that.”
Biogen, based in Cambridge, Massachusetts, leads the market with five MS drugs and is on a mission to use new technologies to gather round-the-clock data on patients. It has run a Fitbit study to see if fitness bands could be reliable data-gathering tools, and is developing an iPad app with the Cleveland Clinic to help physicians better assess their patients’ disease progression.

Different Paths

While Rudick and Conrad declined to comment on the terms of the deal, Conrad said it would probably be a multiyear effort.   
 Keep CURRENT with MS  News - OPT-IN here


No comments: